The Elicit Journal of Medical Science and Discovery (EJMSD) is a peer-reviewed, open-access scholarly journal published by Elicit Publishing Limited, dedicated to advancing the frontiers of medical science and biomedical discovery. The journal provides a platform for original research, critical reviews, clinical studies, case reports, and innovative methodologies that contribute to the understanding, prevention, diagnosis, and treatment of human health and diseases.
EJMSD is committed to publishing high-quality, evidence-based research that bridges the gap between laboratory discoveries and clinical applications, thereby promoting health innovations, global healthcare solutions, and sustainable medical practices.
Scope of the Journal
The journal welcomes interdisciplinary contributions across, but not limited to, the following areas:
Basic Medical Sciences: Physiology, anatomy, pathology, pharmacology, biochemistry, microbiology, and molecular biology.
Clinical Medicine and Therapeutics: Internal medicine, surgery, pediatrics, obstetrics and gynecology, dermatology, oncology, cardiology, neurology, and infectious diseases.
Public and Global Health: Epidemiology, preventive medicine, health promotion, health policy, and global disease burden.
Biomedical Innovations and Technologies: Medical diagnostics, AI in healthcare, bioengineering, telemedicine, wearable technologies, and personalized medicine.
Translational and Regenerative Medicine: Stem cell research, gene therapy, nanomedicine, and novel therapeutic strategies.
Medical Education and Health Systems Research: Innovative teaching methods, digital learning in medicine, and healthcare workforce development.
Authors are invited to make a submission to this journal. All submissions will be assessed by an editor to determine whether they meet the aims and scope of this journal. Those considered to be a good fit will be sent for peer review before determining whether they will be accepted or rejected.
Before making a submission, authors are responsible for obtaining permission to publish any material included with the submission, such as photos, documents and datasets. All authors identified on the submission must consent to be identified as an author. Where appropriate, research should be approved by an appropriate ethics committee in accordance with the legal requirements of the study's country.
An editor may desk reject a submission if it does not meet minimum standards of quality. Before submitting, please ensure that the study design and research argument are structured and articulated properly. The title should be concise and the abstract should be able to stand on its own. This will increase the likelihood of reviewers agreeing to review the paper. When you're satisfied that your submission meets this standard, please follow the checklist below to prepare your submission.
The average time between submission and final decision is 30 to 60 working days and the average time between acceptance and final publication is 10 to 15 days.
The journal is published biannual (2 issues per year: June & December).